Vimian Group AB (publ) (VIMGF)
USD 3.62
(0.0%)
USD 3.62
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 229.42 Million EUR | 8.03% |
| 2022 | 54.43 Million USD | 25.82% |
| 2021 | 43.26 Million USD | 107.42% |
| 2020 | 20.85 Million USD | 439.69% |
| 2019 | 3.86 Million USD | 537.09% |
| 2018 | 606.67 Thousand EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 61.21 Million USD | -4.6% |
| 2024 Q2 | 20.81 Million USD | 1.46% |
| 2024 Q1 | 63.24 Million EUR | 8.87% |
| 2023 FY | 58.8 Million USD | 8.03% |
| 2023 Q2 | 16.45 Million USD | -21.69% |
| 2023 Q1 | 21 Million USD | 70.61% |
| 2023 Q3 | 12.62 Million USD | -23.28% |
| 2023 Q4 | 4.5 Million USD | -64.3% |
| 2022 Q3 | 8.7 Million USD | -34.39% |
| 2022 FY | 54.43 Million USD | 25.82% |
| 2022 Q4 | 12.31 Million USD | 41.48% |
| 2022 Q2 | 13.26 Million EUR | -23.77% |
| 2022 Q1 | 17.4 Million EUR | 175.19% |
| 2021 FY | 43.26 Million USD | 107.42% |
| 2021 Q3 | 6.29 Million EUR | -38.19% |
| 2021 Q4 | 6.32 Million EUR | 0.51% |
| 2021 Q2 | 10.17 Million EUR | -25.11% |
| 2021 Q1 | 13.59 Million EUR | -79.8% |
| 2020 Q4 | 67.27 Million EUR | 420.83% |
| 2020 FY | 20.85 Million USD | 439.69% |
| 2020 Q2 | 8.04 Million EUR | 10.52% |
| 2020 Q1 | 7.27 Million EUR | 0.0% |
| 2020 Q3 | 12.91 Million EUR | 60.56% |
| 2019 FY | 3.86 Million USD | 537.09% |
| 2018 FY | 606.67 Thousand EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 118973.575% |
| Arrayit Corporation | 2.57 Million USD | -8809.547% |
| Atlantic International Corp. | -154.23 Thousand USD | 148851.896% |
| Biocept, Inc. | -2.58 Million USD | 8985.593% |
| Bioqual, Inc. | 7.42 Million USD | -2988.193% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -83025.362% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 96.596% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -12687.904% |
| iMD Companies, Inc. | -23.63 Thousand USD | 970722.329% |
| IDenta Corp. | 662.97 Thousand USD | -34505.528% |
| Interpace Biosciences, Inc. | 23.04 Million USD | -895.643% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -295662.592% |
| InVitro International | 635.98 Thousand USD | -35974.121% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | -3395.749% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -20896.555% |
| NovelStem International Corp. | 12 Thousand USD | -1911783.333% |
| Optigenex Inc. | -102.96 Thousand USD | 222917.241% |
| PharmChem, Inc. | 3.9 Million USD | -5776.125% |
| Proteome Sciences plc | 2.09 Million USD | -10842.603% |
| Response Genetics, Inc | 3.94 Million USD | -5720.041% |
| Rennova Health, Inc. | 6.26 Million USD | -3560.128% |
| RushNet, Inc. | 1.1 Million USD | -20669.77% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -26684.142% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 56924.199% |
| Todos Medical Ltd. | 4.31 Million USD | -5223.109% |